1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Relapsing-Remitting Multiple Sclerosis (RRMS): new trials by email Literature Review of Relapsing-Remitting Multiple Sclerosis (RRMS) trials Research Report on Relapsing-Remitting Multiple Sclerosis (RRMS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Plegridy Satisfaction Study in Participants peginterferon beta-1a - Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 4 | Completed | Biogen | 193 | 2016-02-03 | 2023-08-31 |
| Brimonidine Tartrate for the Treatment of Injection Related Erythema peginterferon beta-1a, brimonidine tartrate, Vehicle Gel - Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 4 | Withdrawn | Biogen | 2016-02-01 | 2016-04-25 |
Multiple Sclerosis, Relapsing-Remitting (2) · Erythema (1) · Injection Site Reaction (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Multiple Sclerosis (2) · Nervous System Diseases (2) · Chemically-Induced Disorders (1) · Drug-Related Side Effects and Adverse Reactions (1) · Extravasation of Diagnostic and Therapeutic Materials (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin Manifestations (1)
peginterferon beta-1a (2) · Brimonidine Tartrate (1)
Biogen (2)
Italy (1)
2015 (2)